Epizyme

+$0.08 (+3.98%) As of 2:33 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Epizyme and other ETFs, options, and stocks.

About EPZM

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases.

CEO
Grant C. Bogle
Employees
304
Headquarters
Cambridge, Massachusetts
Founded
2007

EPZM Key Statistics

Market cap
218.22M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.42M
High today
$2.09
Low today
$2.02
Open price
$2.02
Volume
10.88K
52 Week high
$12.37
52 Week low
$1.84

EPZM Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure